TAU discovery sheds new light on elusive workings of ALS
Researchers from Tel Aviv University (TAU) have identified a previously unknown intracellular process in amyotrophic lateral sclerosis (ALS) that may serve as a basis for the development of new treatments for the fatal neurodegenerative disease. “Our discovery provides new encouragement for developing ALS treatments,” says the study’s lead researcher, Professor Eran Perlson of the Department… Read More